Boston, Mass - US-based Graticule and France based Medexprim announced a partnership today to provide a
federated global network to power complex RWE (Real World Evidence) studies. The two companies have
established complementary infrastructure and relationships with health systems and health technology vendors to
support research on deidentified radiology data combined with longitudinal health records. Jointly Graticule and
Medexprim provide Life Sciences and AI technology clients with a global solution to advance medical research and
development across multiple types of projects including HEOR (Health Economics and Outcomes Research),
epidemiology, biomarker discovery, feasibility studies, clinical trial recruitment, and AI powered diagnostics.